BD Taps Leading Voice in Infection Prevention Community to Advance Efforts to Reduce Healthcare-Associated Infections

FRANKLIN LAKES, N.J., Nov. 16, 2010 /PRNewswire-FirstCall/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Kathy Warye has joined the Company as Vice President, Infection Prevention.

Prior to joining BD, Ms. Warye served as the Chief Executive Officer of the Association for Professionals in Infection Control and Epidemiology (APIC) for the past six years.  

In this newly created role, Ms. Warye will be based in Washington, D.C., and responsible for:

• Leading BD's efforts to advance best practices and improve patient outcomes.
• Working closely with key opinion leaders globally to define and promote effective methods for reducing infections in the healthcare setting.  
• Serving as the primary liaison to stakeholders in the area of infection prevention.
• Helping BD build collaborative relationships with organizations committed to preventing healthcare-associated infections (HAIs).

"We are very pleased to have Kathy join the BD team. She brings a wealth of knowledge and experience in the area of infection prevention," said Vince Forlenza, President and Chief Operating Officer, BD. "Her expertise and passion will be crucial as BD pursues its commitment to preventing HAIs."

During Ms. Warye's term at the helm of APIC, the organization doubled in size and gained recognition as a global leader in infection prevention.  Ms. Warye was recently ranked #46 among the 100 Most Powerful People in Healthcare by Modern Healthcare magazine.

Prior to joining APIC, Ms. Warye held key management positions in several high-profile organizations in the nation's capital. She oversaw the National Science and Technology Education Partnership's extensive efforts to expand and improve K-12 education programs.  She also served as Senior Vice President of Education and Government Programs for the Association for the Advancement of Medical Instrumentation, where she oversaw its education and certification programs, as well as government affairs and marketing activities.

About BD

BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 associates in more than 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit www.bd.com.

SOURCE BD-Becton Dickinson